MTOR and neoplasm: As mentioned above, PI3K/AKT/mTOR pathway inhibitors (i.e. rapamycin, everolimus) are well-known autophagy inductors [77–79] and their combination with other cytotoxic molecules could enhance antitumor efficacy and restrict repopulation of tumor cells between cycles of cytotoxic drugs.